Scientists are hoping to use genetic engineering to reduce the transmission of Lyme disease. The scientists' target is not ...
CRISPR Therapeutics AG CRSP shares soared 8.7% in the last trading session to close at $76.78. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback